|
1
|
Hess KR, Broglio KR and Bondy ML: Adult
glioma incidence trends in the United States, 1977–2000. Cancer.
101:2293–2299. 2004.PubMed/NCBI
|
|
2
|
Buckner JC: Factors influencing survival
in high-grade gliomas. Semin Oncol. 30:10–14. 2003. View Article : Google Scholar
|
|
3
|
Hegi ME, Diserens AC, Gorlia T, et al:
MGMT gene silencing and benefit from temozolomide in glioblastoma.
N Engl J Med. 352:997–1003. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iwamoto FM, Reiner AS, Nayak L, Panageas
KS, Elkin EB and Abrey LE: Prognosis and patterns of care in
elderly patients with glioma. Cancer. 115:5534–5540. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lacroix M, Abi-Said D, Fourney DR, et al:
A multivariate analysis of 416 patients with glioblastoma
multiforme: prognosis, extent of resection, and survival. J
Neurosurg. 95:190–198. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lamborn KR, Chang SM and Prados MD:
Prognostic factors for survival of patients with glioblastoma:
recursive partitioning analysis. Neuro Oncol. 6:227–235. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lefranc F, Rynkowski M, DeWitte O and Kiss
R: Present and potential future adjuvant issues in high-grade
astrocytic glioma treatment. Adv Tech Stand Neurosurg. 34:3–35.
2009.PubMed/NCBI
|
|
8
|
Li SW, Qiu XG, Chen BS, et al: Prognostic
factors influencing clinical outcomes of glioblastoma multiforme.
Chin Med J (Engl). 122:1245–1249. 2009.PubMed/NCBI
|
|
9
|
McGirt MJ, Chaichana KL, Gathinji M, et
al: Independent association of extent of resection with survival in
patients with malignant brain astrocytoma. J Neurosurg.
110:156–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sanai N and Berger MS: Glioma extent of
resection and its impact on patient outcome. Neurosurgery.
62:753–764. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sanai N, Polley MY, McDermott MW, Parsa AT
and Berger MS: An extent of resection threshold for newly diagnosed
glioblastomas. J Neurosurg. 115:3–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Scott J, Tsai YY, Chinnaiyan P and Yu HH:
Effectiveness of radiotherapy for elderly patients with
glioblastoma. Int J Radiat Oncol Biol Phys. 81:206–210. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stupp R, Hegi ME, Mason WP, et al: Effects
of radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised
phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet
Oncol. 10:459–466. 2009.
|
|
14
|
Stupp R, Mason WP, van den Bent MJ, et al:
Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
CBTRUS: Central Brain Tumor registry of
the United States. http://www.cbtrus.org/.
2008.
|
|
16
|
Zinn PO, Sathyan P, Mahajan B, Bruyere J,
Hegi M, Majumder S and Colen RR: A novel volume-age-KPS (VAK)
glioblastoma classification identifies a prognostic cognate
microRNA-gene signature. PLoS One. 7:e415222012.PubMed/NCBI
|
|
17
|
Marko NF, Toms SA, Barnett GH and Weil R:
Genomic expression patterns distinguish long-term from short-term
glioblastoma survivors: a preliminary feasibility study. Genomics.
91:395–406. 2008. View Article : Google Scholar
|
|
18
|
Phillips HS, Kharbanda S, Chen R, et al:
Molecular subclasses of high-grade glioma predict prognosis,
delineate a pattern of disease progression, and resemble stages in
neurogenesis. Cancer Cell. 9:157–173. 2006. View Article : Google Scholar
|
|
19
|
Colman H, Zhang L, Sulman EP, et al: A
multigene predictor of outcome in glioblastoma. Neuro Oncol.
12:49–57. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cooper LA, Gutman DA, Long Q, et al: The
proneural molecular signature is enriched in oligodendrogliomas and
predicts improved survival among diffuse gliomas. PLoS One.
5:e125482010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zinn PO, Majadan B, Sathyan P, et al:
Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in
glioblastoma multiforme. PLoS One. 6:e254512011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Johnson DR and O’Neill BP: Glioblastoma
survival in the United States before and during the temozolomide
era. J Neurooncol. 107:359–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koshy M, Villano JL, Dolecek TA, et al:
Improved survival time trends for glioblastoma using the SEER 17
population-based registries. J Neurooncol. 107:207–212. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barnholtz-Sloan JS, Sloan AE and Schwartz
AG: Racial differences in survival after diagnosis with primary
malignant brain tumor. Cancer. 98:603–609. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barnholtz-Sloan JS, Maldonado JL, Williams
VL, et al: Racial/ethnic differences in survival among elderly
patients with a primary glioblastoma. J Neurooncol. 85:171–180.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ang C, Guiot MC, Ramanakumar AV, Roberge D
and Kavan P: Clinical significance of molecular biomarkers in
glioblastoma. Can J Neurol Sci. 37:625–630. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kanu OO, Hughes B, Di C, et al:
Glioblastoma multiforme oncogenomics and signaling pathways. Clin
Med Oncol. 3:39–52. 2009.PubMed/NCBI
|
|
28
|
Chang JE, Khuntia D, Robins HI and Mehta
MP: Radiotherapy and radiosensitizers in the treatment of
glioblastoma multi-forme. Clin Adv Hematol Oncol. 5:894–915.
2007.PubMed/NCBI
|
|
29
|
Clarke J, Butowski N and Chang S: Recent
advances in therapy for glioblastoma. Arch Neurol. 67:279–283.
2010. View Article : Google Scholar
|
|
30
|
Keime-Guibert F, Chinot O, Taillandier L,
et al: Radiotherapy for glioblastoma in the elderly. N Engl J Med.
356:1527–1535. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lai R, Hershman DL, Doan T and Neugut AI:
The timing of cranial radiation in elderly patients with newly
diagnosed glioblastoma multiforme. Neuro Oncol. 12:190–198. 2010.
View Article : Google Scholar : PubMed/NCBI
|
